Quarterly Report · 10-Q
STERIS plc STE NYSE EQUITY Current
Add to THEMA watchlist → Follow this company’s filings → Quarterly Report Filed Nov 5, 2026 Accepted Nov 5, 2026, 4:04 PM EST CIK 1757898 Accession 0001628280-26-070997
Company context STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. For more information, visit www.steris.com.
Current securities Registered securities in this filing STERIS plc · 10-Q · Filed 2026-11-05
As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.
Ordinary Shares, $0.001 par value
Exchange NYSE
Classification COMMON
Status Current Filing context Context: c-2
Dimensions: us-gaap:StatementClassOfStockAxis
2.700% Senior Notes due 2031
Symbol STE/31
Exchange NYSE
Classification DEBT Filing context Context: c-3
Dimensions: us-gaap:StatementClassOfStockAxis
3.750% Senior Notes due 2051
Symbol STE/51
Exchange NYSE
Classification DEBT Filing context Context: c-4
Dimensions: us-gaap:StatementClassOfStockAxis
Accession 000162828026070997 · 3 registered-security cover members
Read the exact SEC filing ↗
As-filed source Primary evidence